Barr Pharm., Inc
Article Abstract:
The shares of Barr Pharmaceuticals Inc. have better-than-average price appreciation potential over the 2010-2012 timeframe. The Pomona, New York-based company offers generic and proprietary pharmaceutical products for treatment of cancer, hypertension, heart disease, depression, and hormone replacement.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
BRL, Barr Pharmaceuticals Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
NPS Pharm., Inc
Article Abstract:
The price appreciation potential of NPS Pharmaceuticals, Inc. for the years 2010-2012 is discussed. The Salt Lake City, Utah -based company sells drugs for hyperthyroidism, parathyroid carcinoma, and osteoporosis .
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
NPS Pharmaceuticals Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: United States, Evaluation, Pharmaceutical industry, Stocks, Securities, Stock prices, Company securities
Similar abstracts:
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.